Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.36416/1806-3756/e20210076 http://scihub22266oqcxt.onion/10.36416/1806-3756/e20210076 34287504!8332654!34287504     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34287504&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Bras+Pneumol 2021 ; 47 (4): e20210076 Nephropedia Template TP {{tp|p=34287504|t=2021. Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia |pdf=|usr=}}{{34287504}} gab.com Text Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia JO: J Bras Pneumol http://www.kidney.de/pget.php?&tw=1&pmid=34287504 #FOAvip OBJECTIVE: High prevalences of muscle weakness and impaired physical performance in hospitalized patients recovering from COVID-19-associated pneumonia have been reported. Our objective was to determine whether the level of exercise capacity after discharge would affect long-term functional outcomes in these patients. METHODS: From three to five weeks after discharge from acute care hospitals (T0), patients underwent a six-minute walk test (6MWT) and were divided into two groups according to the distance walked in percentage of predicted values: <75% group and >/=75% group. At T0 and three months later (T1), patients completed the Short Physical Performance Battery and the Euro Quality of Life Visual Analogue Scale, and pulmonary function and respiratory muscle function were assessed. In addition, a repeat 6MWT was also performed at T1. RESULTS: At T0, 6MWD values and Short Physical Performance Battery scores were lower in the <75% group than in the >/=75% group. No differences were found in the Euro Quality of Life Visual Analogue Scale scores, pulmonary function variables, respiratory muscle function variables, length of hospital stay, or previous treatment. At T1, both groups improved their exercise capacity, but only the subjects in the <75% group showed significant improvements in dyspnea and lower extremity function. Exercise capacity and functional status values returned to predicted values in all of the patients in both groups. CONCLUSIONS: Four weeks after discharge, COVID-19 survivors with exercise limitation showed no significant differences in physiological or clinical characteristics or in perceived health status when compared with patients without exercise limitation. Three months later, those patients recovered their exercise capacity. Twit Text FOAVip Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia ????J Bras Pneumol http://www.kidney.de/pget.php?&tw=1&pmid=34287504 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34287504 #FOAvip English Wikipedia <ref>{{Cite pmid|34287504}}</ref> Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia #MMPMID34287504 Zampogna E; Ambrosino N; Saderi L; Sotgiu G; Bottini P; Pignatti P; Centis R; Migliori GB; Spanevello A; Zappa M; Visca D J Bras Pneumol 2021[]; 47 (4): e20210076 PMID34287504show ga OBJECTIVE: High prevalences of muscle weakness and impaired physical performance in hospitalized patients recovering from COVID-19-associated pneumonia have been reported. Our objective was to determine whether the level of exercise capacity after discharge would affect long-term functional outcomes in these patients. METHODS: From three to five weeks after discharge from acute care hospitals (T0), patients underwent a six-minute walk test (6MWT) and were divided into two groups according to the distance walked in percentage of predicted values: <75% group and >/=75% group. At T0 and three months later (T1), patients completed the Short Physical Performance Battery and the Euro Quality of Life Visual Analogue Scale, and pulmonary function and respiratory muscle function were assessed. In addition, a repeat 6MWT was also performed at T1. RESULTS: At T0, 6MWD values and Short Physical Performance Battery scores were lower in the <75% group than in the >/=75% group. No differences were found in the Euro Quality of Life Visual Analogue Scale scores, pulmonary function variables, respiratory muscle function variables, length of hospital stay, or previous treatment. At T1, both groups improved their exercise capacity, but only the subjects in the <75% group showed significant improvements in dyspnea and lower extremity function. Exercise capacity and functional status values returned to predicted values in all of the patients in both groups. CONCLUSIONS: Four weeks after discharge, COVID-19 survivors with exercise limitation showed no significant differences in physiological or clinical characteristics or in perceived health status when compared with patients without exercise limitation. Three months later, those patients recovered their exercise capacity. |*COVID-19[MESH] |*Exercise Tolerance[MESH] |Exercise Test[MESH] |Humans[MESH] |Quality of Life[MESH] |Respiration[MESH]Time course of exercise capacity in patients recovering from COVID-19-(epmc).pdf DeepDyve Pubget Overpricing